한글목차

외용제 수탁 개발 제조기관(CDMO) 시장 규모는 최근 급성장하고 있습니다. 2025년 611억 6,000만 달러에서 2026년에는 709억 6,000만 달러에 이르고, CAGR 16.0%의 성장이 전망되고 있습니다. 지난 수년간의 성장은 의약품 아웃소싱 확대, 피부질환 유병률 증가, 제약사의 비용 최적화, 규제 복잡화, 제네릭 외용제의 보급 확대 등이 요인으로 작용한 것으로 분석됩니다.

외용제 수탁 개발 제조 기관(CDMO) 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 1,212억 2,000만 달러에 이르고, CAGR은 14.3%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 첨단 외용제 개발 증가, 경피용 패치 수요 증가, 중소 제약사의 파이프라인 확대, 확장 가능한 제조에 대한 수요 증가, 시장 출시 속도에 대한 집중도 강화 등을 꼽았습니다. 예측 기간의 주요 동향으로는 외용제 제조 아웃소싱 증가, 복잡한 외용제 수요 증가, 경피 약물 전달 플랫폼 확대, 규제 준수 제조에 대한 집중 강화, 엔드투엔드 CDMO 서비스에 대한 수요 증가 등이 있습니다.

피부질환 발생률 증가는 향후 외용제 위탁개발생산기관(CDMO) 시장의 확대를 촉진할 것으로 예측됩니다. 피부질환은 피부에 영향을 미치는 병태로 염증, 가려움증, 병변 등의 증상을 유발합니다. 이러한 피부질환 증가는 환경오염, 자외선 노출, 유전적 요인, 생활습관 변화, 미생물 감염 등의 요인에 기인합니다. 외용제 CDMO는 피부질환의 치료와 관리를 개선하는 전문 치료제를 개발 및 제조하여 피부질환 발생률 감소에 기여하고 있습니다. 예를 들어, 호주 정부 기관인 Cancer Australia는 2023년 약 8,257건의 피부 흑색종이 새로 진단되어 전체 암 관련 사망의 2.6%를 차지했다고 보고했습니다. 이러한 피부질환의 유병률 증가는 외용제 CDMO 시장의 성장을 가속하고 있습니다.

외용제 CDMO 시장의 주요 기업들은 경쟁 우위를 유지하기 위해 최첨단 제조 시설에 투자하고 있습니다. 최첨단 제조시설이란 외용제 개발 및 제조에 특화된 전용 생산기지로 최신 기술과 고도의 공정을 갖춘 생산기지입니다. 예를 들어, 2023년 11월 미국 제약회사 SOHM은 GMP를 준수하는 CDMO 시설을 개설했습니다. 새로운 칼스배드 사업장은 외용 제품 제조 및 SOHM의 활동을 위한 충분한 공간을 제공하며, 완제품 보관에 필요한 2,500평방피트 규모의 공간을 확보했습니다. 초기에는 외용제 1일 500갤런(1,892리터)의 생산능력으로 시작하여, 2024년 1분기 말 또는 2분기 초까지 소프트젤 좌약 생산 규모를 확대할 계획입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

A topical drugs CDMO is a specialized firm offering end-to-end services for developing, formulating, and manufacturing topical pharmaceuticals. These services cover research and development, production of clinical trial materials, and commercial-scale manufacturing. CDMOs enable pharmaceutical companies to efficiently and compliantly launch topical drug products to market.

The primary product categories offered by topical drug contract development and manufacturing organizations (CDMOs) consist of semi-solid formulations, liquid formulations, solid formulations, and transdermal products. Semi-solid formulations encompass creams, ointments, gels, and pastes intended for topical use. A range of service types is available, including contract development and contract manufacturing across diverse therapeutic fields like dermatology, pain management, wound care, and ophthalmology, among others. These are utilized by various end-users, such as pharmaceutical companies, biopharmaceutical companies, and additional entities.

Tariffs have impacted the topical drugs CDMO market by increasing costs of imported excipients, packaging materials, and specialized manufacturing equipment. Semi-solid and transdermal product segments are most affected, particularly in regions dependent on cross-border sourcing such as Asia-Pacific and Europe. Higher tariffs may raise contract manufacturing costs and extend development timelines. However, tariffs are encouraging localized manufacturing investments and supply chain diversification.

The topical drugs contract development and manufacturing organization (cdmo) market research report is one of a series of new reports from The Business Research Company that provides topical drugs contract development and manufacturing organization (cdmo) market statistics, including topical drugs contract development and manufacturing organization (cdmo) industry global market size, regional shares, competitors with a topical drugs contract development and manufacturing organization (cdmo) market share, detailed topical drugs contract development and manufacturing organization (cdmo) market segments, market trends and opportunities, and any further data you may need to thrive in the topical drugs contract development and manufacturing organization (cdmo) industry. This topical drugs contract development and manufacturing organization (cdmo) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The topical drugs contract development and manufacturing organization (cdmo) market size has grown rapidly in recent years. It will grow from $61.16 billion in 2025 to $70.96 billion in 2026 at a compound annual growth rate (CAGR) of 16.0%. The growth in the historic period can be attributed to growth in pharmaceutical outsourcing, rising prevalence of dermatological conditions, cost optimization by pharmaceutical companies, increasing regulatory complexity, expansion of generic topical drugs.

The topical drugs contract development and manufacturing organization (cdmo) market size is expected to see rapid growth in the next few years. It will grow to $121.22 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to increasing development of advanced topical therapies, rising demand for transdermal patches, expansion of small and mid-sized pharma pipelines, growing need for scalable manufacturing, increased focus on speed to market. Major trends in the forecast period include rising outsourcing of topical drug manufacturing, growing demand for complex topical formulations, expansion of transdermal drug delivery platforms, increasing focus on regulatory-compliant manufacturing, higher demand for end-to-end CDMO services.

The rising incidence of skin diseases is anticipated to boost the expansion of the topical drugs contract development and manufacturing organization (CDMO) market in the future. Skin diseases are medical conditions impacting the skin, leading to symptoms like inflammation, itching, and lesions. This uptick in skin diseases stems from factors including environmental pollution, UV radiation exposure, genetic factors, lifestyle shifts, and microbial infections. Topical drugs CDMOs contribute to lowering skin disease rates by creating and producing specialized therapies that enhance the treatment and control of dermatological issues. For instance, in 2023, Cancer Australia-a government agency in Australia-reported around 8,257 new diagnoses of skin melanoma, representing 2.6% of all cancer-related deaths. Thus, the growing prevalence of skin diseases is fueling the topical drugs CDMO market's growth.

Major players in the topical drugs CDMO market are investing in cutting-edge manufacturing sites to maintain their competitive edge. A cutting-edge manufacturing site represents a dedicated production hub outfitted with the newest technologies and sophisticated processes, specifically designed for creating and producing topical pharmaceuticals. For example, in November 2023, SOHM Inc., a U.S.-based pharma firm, opened a GMP-compliant CDMO facility. The new Carlsbad site provides generous space for topical product manufacturing and SOHM's activities, including 2,500 square feet for finished goods storage. It starts with a daily output of 500 gallons (1,892 liters) for topicals, with plans to scale up by the end of Q1 2024 or early Q2 2024 to encompass soft-gel suppositories.

In April 2024, CoreRx Inc., a U.S.-based pharmaceutical firm, purchased Societal CDMO Inc. for $130 million. This deal aims to bolster CoreRx as a more robust CDMO, broadening its offerings from early-stage development through to commercial production. It promises to optimize operations, boost market presence, and deliver enduring advantages like enhanced economies of scale, superior R&D capabilities, and a firmer competitive edge. Societal CDMO Inc. is a U.S.-based contract development and manufacturing organization focused on creating and producing innovative drug delivery formulations.

Major companies operating in the topical drugs contract development and manufacturing organization (cdmo) market are Catalent Inc., Lonza Group AG, Recipharm AB, Piramal Pharma Solutions, Cambrex Corporation, PCI Pharma Services, Famar S.A., Contract Pharmaceuticals Limited, UPM Pharmaceuticals Inc., MedPharm Ltd, Tergus Pharma LLC, NextPharma Technologies Holding Limited, Bora Pharmaceuticals Co. Ltd., LTS Lohmann Therapie-Systeme AG, CoreRx Inc., Halo Pharmaceutical Inc., Tapemark Company, Groupe PARIMA Inc., Dow Development Laboratories LLC, Tedor Pharma Inc.

Asia-Pacific was the largest region in the topical drugs contract development and manufacturing organization (CDMO) market in 2025. The regions covered in the topical drugs contract development and manufacturing organization (cdmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the topical drugs contract development and manufacturing organization (cdmo) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The topical drugs contract development and manufacturing organization (CDMO) market consists of revenues earned by entities by providing services such as commercial manufacturing, research and development (R&D), regulatory support, and product lifecycle management. The market value includes the value of related goods sold by the service provider or included within the service offering. The topical drugs contract development and manufacturing organization (CDMO) market also includes sales of creams, ointments, gels, and lotions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses topical drugs contract development and manufacturing organization (cdmo) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for topical drugs contract development and manufacturing organization (cdmo) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The topical drugs contract development and manufacturing organization (cdmo) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Semi-Solid Formulations; Liquid Formulations Drugs; Solid Formulations; Transdermal Products
• 2) By Service Type: Contract Development; Contract Manufacturing
• 3) By Therapeutic Area: Dermatology; Pain Management; Wound Care; Ophthalmology; Other Therapeutic Areas
• 4) By End-Use: Pharmaceutical Companies; Biopharmaceutical Companies; Other End-Uses
• Subsegments:
• 1) By Semi-Solid Formulations: Creams; Ointments; Gels; Pastes
• 2) By Liquid Formulations Drugs: Solutions; Suspensions; Emulsions; Lotions
• 3) By Solid Formulations: Powders
• 4) By Transdermal Products: Patches
• Companies Mentioned: Catalent Inc.; Lonza Group AG; Recipharm AB; Piramal Pharma Solutions; Cambrex Corporation; PCI Pharma Services; Famar S.A.; Contract Pharmaceuticals Limited; UPM Pharmaceuticals Inc.; MedPharm Ltd; Tergus Pharma LLC; NextPharma Technologies Holding Limited; Bora Pharmaceuticals Co. Ltd.; LTS Lohmann Therapie-Systeme AG; CoreRx Inc.; Halo Pharmaceutical Inc.; Tapemark Company; Groupe PARIMA Inc.; Dow Development Laboratories LLC; Tedor Pharma Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Industry 4.0 & Intelligent Manufacturing
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Biotechnology, Genomics & Precision Medicine
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Rising Outsourcing Of Topical Drug Manufacturing
  • 4.2.2 Growing Demand For Complex Topical Formulations
  • 4.2.3 Expansion Of Transdermal Drug Delivery Platforms
  • 4.2.4 Increasing Focus On Regulatory-Compliant Manufacturing
  • 4.2.5 Higher Demand For End-To-End Cdmo Services

5. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Companies
• 5.2 Biopharmaceutical Companies
• 5.3 Generic Drug Manufacturers
• 5.4 Specialty Dermatology Companies
• 5.5 Virtual Pharma Companies

6. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Segmentation

• 9.1. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products
• 9.2. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Contract Development, Contract Manufacturing
• 9.3. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Dermatology, Pain Management, Wound Care, Ophthalmology, Other Therapeutic Areas
• 9.4. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses
• 9.5. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Semi-Solid Formulations, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Creams, Ointments, Gels, Pastes
• 9.6. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Liquid Formulations Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Solutions, Suspensions, Emulsions, Lotions
• 9.7. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Solid Formulations, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Powders
• 9.8. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Transdermal Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Patches

10. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Regional And Country Analysis

• 10.1. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 11.1. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 12.1. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 13.1. India Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 14.1. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 15.1. Australia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 16.1. Indonesia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 17.1. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 18.1. Taiwan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 19.1. South East Asia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 20.1. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 21.1. UK Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 22.1. Germany Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 23.1. France Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 24.1. Italy Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 25.1. Spain Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 26.1. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 27.1. Russia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 28.1. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 29.1. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 30.1. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 31.1. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 32.1. Brazil Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 33.1. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 34.1. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Segmentation By Service Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Regulatory and Investment Landscape

36. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Company Profiles

• 36.1. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Company Profiles
  • 36.3.1. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Recipharm AB Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Piramal Pharma Solutions Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Cambrex Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Other Major And Innovative Companies

• PCI Pharma Services, Famar S.A., Contract Pharmaceuticals Limited, UPM Pharmaceuticals Inc., MedPharm Ltd, Tergus Pharma LLC, NextPharma Technologies Holding Limited, Bora Pharmaceuticals Co. Ltd., LTS Lohmann Therapie-Systeme AG, CoreRx Inc., Halo Pharmaceutical Inc., Tapemark Company, Groupe PARIMA Inc., Dow Development Laboratories LLC, Tedor Pharma Inc.

38. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

40. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market High Potential Countries, Segments and Strategies

• 40.1 Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer